nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvoxamine—CYP2E1—liver cancer	0.237	0.503	CbGaD
Fluvoxamine—CYP1A1—liver cancer	0.234	0.497	CbGaD
Fluvoxamine—CYP3A7-CYP3A51P—Sorafenib—liver cancer	0.0396	0.126	CbGbCtD
Fluvoxamine—CYP3A7—Sorafenib—liver cancer	0.0396	0.126	CbGbCtD
Fluvoxamine—CYP2B6—Sorafenib—liver cancer	0.0377	0.12	CbGbCtD
Fluvoxamine—CYP3A5—Sorafenib—liver cancer	0.0297	0.0945	CbGbCtD
Fluvoxamine—CYP2C19—Sorafenib—liver cancer	0.024	0.0762	CbGbCtD
Fluvoxamine—CYP2B6—Doxorubicin—liver cancer	0.0229	0.0728	CbGbCtD
Fluvoxamine—CYP1A2—Sorafenib—liver cancer	0.0221	0.0703	CbGbCtD
Fluvoxamine—CYP2C9—Sorafenib—liver cancer	0.0199	0.0634	CbGbCtD
Fluvoxamine—ABCB1—Sorafenib—liver cancer	0.0193	0.0615	CbGbCtD
Fluvoxamine—CYP2D6—Sorafenib—liver cancer	0.0182	0.0579	CbGbCtD
Fluvoxamine—ABCB1—Doxorubicin—liver cancer	0.0117	0.0373	CbGbCtD
Fluvoxamine—CYP3A4—Sorafenib—liver cancer	0.0116	0.0368	CbGbCtD
Fluvoxamine—CYP2D6—Doxorubicin—liver cancer	0.0111	0.0352	CbGbCtD
Fluvoxamine—CYP3A4—Doxorubicin—liver cancer	0.00703	0.0224	CbGbCtD
Fluvoxamine—Affect lability—Doxorubicin—liver cancer	0.000164	0.0012	CcSEcCtD
Fluvoxamine—Hypokalaemia—Epirubicin—liver cancer	0.000164	0.0012	CcSEcCtD
Fluvoxamine—Diarrhoea—Sorafenib—liver cancer	0.000164	0.0012	CcSEcCtD
Fluvoxamine—Breast disorder—Epirubicin—liver cancer	0.000163	0.00119	CcSEcCtD
Fluvoxamine—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.000162	0.00119	CcSEcCtD
Fluvoxamine—Face oedema—Doxorubicin—liver cancer	0.000161	0.00118	CcSEcCtD
Fluvoxamine—Gastritis—Epirubicin—liver cancer	0.000159	0.00117	CcSEcCtD
Fluvoxamine—Muscular weakness—Epirubicin—liver cancer	0.000159	0.00116	CcSEcCtD
Fluvoxamine—Cardiac arrest—Doxorubicin—liver cancer	0.000158	0.00116	CcSEcCtD
Fluvoxamine—Dizziness—Sorafenib—liver cancer	0.000158	0.00116	CcSEcCtD
Fluvoxamine—Mood swings—Doxorubicin—liver cancer	0.000158	0.00115	CcSEcCtD
Fluvoxamine—Abdominal distension—Epirubicin—liver cancer	0.000157	0.00115	CcSEcCtD
Fluvoxamine—Ataxia—Doxorubicin—liver cancer	0.000157	0.00115	CcSEcCtD
Fluvoxamine—Influenza—Epirubicin—liver cancer	0.000156	0.00114	CcSEcCtD
Fluvoxamine—Dysphagia—Epirubicin—liver cancer	0.000156	0.00114	CcSEcCtD
Fluvoxamine—Asthma—Epirubicin—liver cancer	0.000156	0.00114	CcSEcCtD
Fluvoxamine—Dehydration—Doxorubicin—liver cancer	0.000155	0.00113	CcSEcCtD
Fluvoxamine—Liver function test abnormal—Doxorubicin—liver cancer	0.000154	0.00113	CcSEcCtD
Fluvoxamine—Dry skin—Doxorubicin—liver cancer	0.000153	0.00112	CcSEcCtD
Fluvoxamine—Pancreatitis—Epirubicin—liver cancer	0.000153	0.00112	CcSEcCtD
Fluvoxamine—Vomiting—Sorafenib—liver cancer	0.000152	0.00111	CcSEcCtD
Fluvoxamine—Orthostatic hypotension—Doxorubicin—liver cancer	0.000152	0.00111	CcSEcCtD
Fluvoxamine—Hypokalaemia—Doxorubicin—liver cancer	0.000152	0.00111	CcSEcCtD
Fluvoxamine—Angina pectoris—Epirubicin—liver cancer	0.000152	0.00111	CcSEcCtD
Fluvoxamine—Rash—Sorafenib—liver cancer	0.000151	0.0011	CcSEcCtD
Fluvoxamine—Dermatitis—Sorafenib—liver cancer	0.000151	0.0011	CcSEcCtD
Fluvoxamine—Breast disorder—Doxorubicin—liver cancer	0.000151	0.0011	CcSEcCtD
Fluvoxamine—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.00015	0.0011	CcSEcCtD
Fluvoxamine—Headache—Sorafenib—liver cancer	0.00015	0.0011	CcSEcCtD
Fluvoxamine—Bronchitis—Epirubicin—liver cancer	0.00015	0.00109	CcSEcCtD
Fluvoxamine—Gastritis—Doxorubicin—liver cancer	0.000147	0.00108	CcSEcCtD
Fluvoxamine—Muscular weakness—Doxorubicin—liver cancer	0.000147	0.00107	CcSEcCtD
Fluvoxamine—Dysuria—Epirubicin—liver cancer	0.000145	0.00106	CcSEcCtD
Fluvoxamine—Abdominal distension—Doxorubicin—liver cancer	0.000145	0.00106	CcSEcCtD
Fluvoxamine—Upper respiratory tract infection—Epirubicin—liver cancer	0.000145	0.00106	CcSEcCtD
Fluvoxamine—Asthma—Doxorubicin—liver cancer	0.000144	0.00105	CcSEcCtD
Fluvoxamine—Influenza—Doxorubicin—liver cancer	0.000144	0.00105	CcSEcCtD
Fluvoxamine—Dysphagia—Doxorubicin—liver cancer	0.000144	0.00105	CcSEcCtD
Fluvoxamine—Pollakiuria—Epirubicin—liver cancer	0.000144	0.00105	CcSEcCtD
Fluvoxamine—Nausea—Sorafenib—liver cancer	0.000142	0.00104	CcSEcCtD
Fluvoxamine—Photosensitivity reaction—Epirubicin—liver cancer	0.000142	0.00104	CcSEcCtD
Fluvoxamine—Weight increased—Epirubicin—liver cancer	0.000142	0.00104	CcSEcCtD
Fluvoxamine—Pancreatitis—Doxorubicin—liver cancer	0.000141	0.00103	CcSEcCtD
Fluvoxamine—Weight decreased—Epirubicin—liver cancer	0.000141	0.00103	CcSEcCtD
Fluvoxamine—Hyperglycaemia—Epirubicin—liver cancer	0.00014	0.00103	CcSEcCtD
Fluvoxamine—Angina pectoris—Doxorubicin—liver cancer	0.00014	0.00103	CcSEcCtD
Fluvoxamine—Pneumonia—Epirubicin—liver cancer	0.00014	0.00102	CcSEcCtD
Fluvoxamine—Drowsiness—Epirubicin—liver cancer	0.000139	0.00101	CcSEcCtD
Fluvoxamine—Bronchitis—Doxorubicin—liver cancer	0.000138	0.00101	CcSEcCtD
Fluvoxamine—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000138	0.00101	CcSEcCtD
Fluvoxamine—Renal failure—Epirubicin—liver cancer	0.000136	0.000998	CcSEcCtD
Fluvoxamine—Neuropathy peripheral—Epirubicin—liver cancer	0.000136	0.000995	CcSEcCtD
Fluvoxamine—Stomatitis—Epirubicin—liver cancer	0.000135	0.000989	CcSEcCtD
Fluvoxamine—Jaundice—Epirubicin—liver cancer	0.000135	0.000989	CcSEcCtD
Fluvoxamine—Urinary tract infection—Epirubicin—liver cancer	0.000135	0.000987	CcSEcCtD
Fluvoxamine—Conjunctivitis—Epirubicin—liver cancer	0.000135	0.000987	CcSEcCtD
Fluvoxamine—Dysuria—Doxorubicin—liver cancer	0.000135	0.000985	CcSEcCtD
Fluvoxamine—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000134	0.000979	CcSEcCtD
Fluvoxamine—Sweating—Epirubicin—liver cancer	0.000133	0.000973	CcSEcCtD
Fluvoxamine—Pollakiuria—Doxorubicin—liver cancer	0.000133	0.000973	CcSEcCtD
Fluvoxamine—Haematuria—Epirubicin—liver cancer	0.000132	0.000968	CcSEcCtD
Fluvoxamine—Photosensitivity reaction—Doxorubicin—liver cancer	0.000131	0.000961	CcSEcCtD
Fluvoxamine—Hepatobiliary disease—Epirubicin—liver cancer	0.000131	0.00096	CcSEcCtD
Fluvoxamine—Weight increased—Doxorubicin—liver cancer	0.000131	0.000959	CcSEcCtD
Fluvoxamine—Epistaxis—Epirubicin—liver cancer	0.000131	0.000957	CcSEcCtD
Fluvoxamine—Weight decreased—Doxorubicin—liver cancer	0.00013	0.000953	CcSEcCtD
Fluvoxamine—Sinusitis—Epirubicin—liver cancer	0.00013	0.000952	CcSEcCtD
Fluvoxamine—Hyperglycaemia—Doxorubicin—liver cancer	0.00013	0.00095	CcSEcCtD
Fluvoxamine—Agranulocytosis—Epirubicin—liver cancer	0.000129	0.000947	CcSEcCtD
Fluvoxamine—Pneumonia—Doxorubicin—liver cancer	0.000129	0.000945	CcSEcCtD
Fluvoxamine—Drowsiness—Doxorubicin—liver cancer	0.000128	0.000939	CcSEcCtD
Fluvoxamine—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000127	0.000931	CcSEcCtD
Fluvoxamine—Bradycardia—Epirubicin—liver cancer	0.000127	0.000928	CcSEcCtD
Fluvoxamine—Renal failure—Doxorubicin—liver cancer	0.000126	0.000923	CcSEcCtD
Fluvoxamine—Neuropathy peripheral—Doxorubicin—liver cancer	0.000126	0.000921	CcSEcCtD
Fluvoxamine—Haemoglobin—Epirubicin—liver cancer	0.000125	0.000916	CcSEcCtD
Fluvoxamine—Jaundice—Doxorubicin—liver cancer	0.000125	0.000915	CcSEcCtD
Fluvoxamine—Stomatitis—Doxorubicin—liver cancer	0.000125	0.000915	CcSEcCtD
Fluvoxamine—Rhinitis—Epirubicin—liver cancer	0.000125	0.000913	CcSEcCtD
Fluvoxamine—Urinary tract infection—Doxorubicin—liver cancer	0.000125	0.000913	CcSEcCtD
Fluvoxamine—Conjunctivitis—Doxorubicin—liver cancer	0.000125	0.000913	CcSEcCtD
Fluvoxamine—Haemorrhage—Epirubicin—liver cancer	0.000125	0.000911	CcSEcCtD
Fluvoxamine—Hepatitis—Epirubicin—liver cancer	0.000125	0.000911	CcSEcCtD
Fluvoxamine—Hypoaesthesia—Epirubicin—liver cancer	0.000124	0.000907	CcSEcCtD
Fluvoxamine—Pharyngitis—Epirubicin—liver cancer	0.000124	0.000904	CcSEcCtD
Fluvoxamine—Sweating—Doxorubicin—liver cancer	0.000123	0.0009	CcSEcCtD
Fluvoxamine—Urinary tract disorder—Epirubicin—liver cancer	0.000123	0.0009	CcSEcCtD
Fluvoxamine—Oedema peripheral—Epirubicin—liver cancer	0.000123	0.000898	CcSEcCtD
Fluvoxamine—Haematuria—Doxorubicin—liver cancer	0.000122	0.000895	CcSEcCtD
Fluvoxamine—Urethral disorder—Epirubicin—liver cancer	0.000122	0.000893	CcSEcCtD
Fluvoxamine—Hepatobiliary disease—Doxorubicin—liver cancer	0.000121	0.000888	CcSEcCtD
Fluvoxamine—Epistaxis—Doxorubicin—liver cancer	0.000121	0.000886	CcSEcCtD
Fluvoxamine—Sinusitis—Doxorubicin—liver cancer	0.00012	0.000881	CcSEcCtD
Fluvoxamine—Visual impairment—Epirubicin—liver cancer	0.00012	0.000878	CcSEcCtD
Fluvoxamine—Agranulocytosis—Doxorubicin—liver cancer	0.00012	0.000876	CcSEcCtD
Fluvoxamine—Erythema multiforme—Epirubicin—liver cancer	0.000118	0.000862	CcSEcCtD
Fluvoxamine—Bradycardia—Doxorubicin—liver cancer	0.000117	0.000858	CcSEcCtD
Fluvoxamine—Eye disorder—Epirubicin—liver cancer	0.000116	0.000852	CcSEcCtD
Fluvoxamine—Tinnitus—Epirubicin—liver cancer	0.000116	0.00085	CcSEcCtD
Fluvoxamine—Haemoglobin—Doxorubicin—liver cancer	0.000116	0.000847	CcSEcCtD
Fluvoxamine—Cardiac disorder—Epirubicin—liver cancer	0.000116	0.000846	CcSEcCtD
Fluvoxamine—Rhinitis—Doxorubicin—liver cancer	0.000116	0.000845	CcSEcCtD
Fluvoxamine—Haemorrhage—Doxorubicin—liver cancer	0.000115	0.000843	CcSEcCtD
Fluvoxamine—Hepatitis—Doxorubicin—liver cancer	0.000115	0.000843	CcSEcCtD
Fluvoxamine—Hypoaesthesia—Doxorubicin—liver cancer	0.000115	0.000839	CcSEcCtD
Fluvoxamine—Pharyngitis—Doxorubicin—liver cancer	0.000114	0.000837	CcSEcCtD
Fluvoxamine—Urinary tract disorder—Doxorubicin—liver cancer	0.000114	0.000833	CcSEcCtD
Fluvoxamine—Oedema peripheral—Doxorubicin—liver cancer	0.000114	0.000831	CcSEcCtD
Fluvoxamine—Angiopathy—Epirubicin—liver cancer	0.000113	0.000827	CcSEcCtD
Fluvoxamine—Urethral disorder—Doxorubicin—liver cancer	0.000113	0.000826	CcSEcCtD
Fluvoxamine—Chills—Epirubicin—liver cancer	0.000112	0.000818	CcSEcCtD
Fluvoxamine—Arrhythmia—Epirubicin—liver cancer	0.000111	0.000814	CcSEcCtD
Fluvoxamine—Visual impairment—Doxorubicin—liver cancer	0.000111	0.000812	CcSEcCtD
Fluvoxamine—Alopecia—Epirubicin—liver cancer	0.00011	0.000805	CcSEcCtD
Fluvoxamine—Mental disorder—Epirubicin—liver cancer	0.000109	0.000798	CcSEcCtD
Fluvoxamine—Erythema multiforme—Doxorubicin—liver cancer	0.000109	0.000797	CcSEcCtD
Fluvoxamine—Malnutrition—Epirubicin—liver cancer	0.000108	0.000793	CcSEcCtD
Fluvoxamine—Eye disorder—Doxorubicin—liver cancer	0.000108	0.000788	CcSEcCtD
Fluvoxamine—Tinnitus—Doxorubicin—liver cancer	0.000107	0.000786	CcSEcCtD
Fluvoxamine—Cardiac disorder—Doxorubicin—liver cancer	0.000107	0.000782	CcSEcCtD
Fluvoxamine—Flatulence—Epirubicin—liver cancer	0.000107	0.000782	CcSEcCtD
Fluvoxamine—Tension—Epirubicin—liver cancer	0.000106	0.000778	CcSEcCtD
Fluvoxamine—Dysgeusia—Epirubicin—liver cancer	0.000106	0.000777	CcSEcCtD
Fluvoxamine—Nervousness—Epirubicin—liver cancer	0.000105	0.00077	CcSEcCtD
Fluvoxamine—Back pain—Epirubicin—liver cancer	0.000105	0.000767	CcSEcCtD
Fluvoxamine—Angiopathy—Doxorubicin—liver cancer	0.000105	0.000765	CcSEcCtD
Fluvoxamine—Muscle spasms—Epirubicin—liver cancer	0.000104	0.000763	CcSEcCtD
Fluvoxamine—Chills—Doxorubicin—liver cancer	0.000103	0.000756	CcSEcCtD
Fluvoxamine—Arrhythmia—Doxorubicin—liver cancer	0.000103	0.000753	CcSEcCtD
Fluvoxamine—Vision blurred—Epirubicin—liver cancer	0.000102	0.000748	CcSEcCtD
Fluvoxamine—Alopecia—Doxorubicin—liver cancer	0.000102	0.000745	CcSEcCtD
Fluvoxamine—Mental disorder—Doxorubicin—liver cancer	0.000101	0.000739	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Epirubicin—liver cancer	0.000101	0.000736	CcSEcCtD
Fluvoxamine—Malnutrition—Doxorubicin—liver cancer	0.0001	0.000734	CcSEcCtD
Fluvoxamine—Anaemia—Epirubicin—liver cancer	0.0001	0.000733	CcSEcCtD
Fluvoxamine—Agitation—Epirubicin—liver cancer	9.96e-05	0.000729	CcSEcCtD
Fluvoxamine—Flatulence—Doxorubicin—liver cancer	9.88e-05	0.000723	CcSEcCtD
Fluvoxamine—Tension—Doxorubicin—liver cancer	9.84e-05	0.00072	CcSEcCtD
Fluvoxamine—Dysgeusia—Doxorubicin—liver cancer	9.82e-05	0.000719	CcSEcCtD
Fluvoxamine—Malaise—Epirubicin—liver cancer	9.78e-05	0.000715	CcSEcCtD
Fluvoxamine—Nervousness—Doxorubicin—liver cancer	9.74e-05	0.000713	CcSEcCtD
Fluvoxamine—Vertigo—Epirubicin—liver cancer	9.74e-05	0.000713	CcSEcCtD
Fluvoxamine—Syncope—Epirubicin—liver cancer	9.72e-05	0.000711	CcSEcCtD
Fluvoxamine—Leukopenia—Epirubicin—liver cancer	9.7e-05	0.00071	CcSEcCtD
Fluvoxamine—Back pain—Doxorubicin—liver cancer	9.7e-05	0.00071	CcSEcCtD
Fluvoxamine—Muscle spasms—Doxorubicin—liver cancer	9.64e-05	0.000706	CcSEcCtD
Fluvoxamine—Palpitations—Epirubicin—liver cancer	9.58e-05	0.000701	CcSEcCtD
Fluvoxamine—Loss of consciousness—Epirubicin—liver cancer	9.53e-05	0.000697	CcSEcCtD
Fluvoxamine—Cough—Epirubicin—liver cancer	9.46e-05	0.000692	CcSEcCtD
Fluvoxamine—Vision blurred—Doxorubicin—liver cancer	9.45e-05	0.000692	CcSEcCtD
Fluvoxamine—Convulsion—Epirubicin—liver cancer	9.39e-05	0.000687	CcSEcCtD
Fluvoxamine—Hypertension—Epirubicin—liver cancer	9.36e-05	0.000685	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Doxorubicin—liver cancer	9.31e-05	0.000681	CcSEcCtD
Fluvoxamine—Anaemia—Doxorubicin—liver cancer	9.27e-05	0.000678	CcSEcCtD
Fluvoxamine—Myalgia—Epirubicin—liver cancer	9.23e-05	0.000675	CcSEcCtD
Fluvoxamine—Chest pain—Epirubicin—liver cancer	9.23e-05	0.000675	CcSEcCtD
Fluvoxamine—Arthralgia—Epirubicin—liver cancer	9.23e-05	0.000675	CcSEcCtD
Fluvoxamine—Agitation—Doxorubicin—liver cancer	9.22e-05	0.000674	CcSEcCtD
Fluvoxamine—Anxiety—Epirubicin—liver cancer	9.2e-05	0.000673	CcSEcCtD
Fluvoxamine—Discomfort—Epirubicin—liver cancer	9.12e-05	0.000667	CcSEcCtD
Fluvoxamine—Malaise—Doxorubicin—liver cancer	9.04e-05	0.000662	CcSEcCtD
Fluvoxamine—Dry mouth—Epirubicin—liver cancer	9.03e-05	0.00066	CcSEcCtD
Fluvoxamine—Vertigo—Doxorubicin—liver cancer	9.01e-05	0.000659	CcSEcCtD
Fluvoxamine—Syncope—Doxorubicin—liver cancer	8.99e-05	0.000658	CcSEcCtD
Fluvoxamine—Leukopenia—Doxorubicin—liver cancer	8.98e-05	0.000657	CcSEcCtD
Fluvoxamine—Confusional state—Epirubicin—liver cancer	8.92e-05	0.000653	CcSEcCtD
Fluvoxamine—Palpitations—Doxorubicin—liver cancer	8.86e-05	0.000649	CcSEcCtD
Fluvoxamine—Oedema—Epirubicin—liver cancer	8.85e-05	0.000647	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Epirubicin—liver cancer	8.85e-05	0.000647	CcSEcCtD
Fluvoxamine—Loss of consciousness—Doxorubicin—liver cancer	8.82e-05	0.000645	CcSEcCtD
Fluvoxamine—Infection—Epirubicin—liver cancer	8.79e-05	0.000643	CcSEcCtD
Fluvoxamine—Cough—Doxorubicin—liver cancer	8.75e-05	0.00064	CcSEcCtD
Fluvoxamine—Shock—Epirubicin—liver cancer	8.7e-05	0.000637	CcSEcCtD
Fluvoxamine—Convulsion—Doxorubicin—liver cancer	8.69e-05	0.000636	CcSEcCtD
Fluvoxamine—Nervous system disorder—Epirubicin—liver cancer	8.68e-05	0.000635	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Epirubicin—liver cancer	8.66e-05	0.000634	CcSEcCtD
Fluvoxamine—Hypertension—Doxorubicin—liver cancer	8.66e-05	0.000634	CcSEcCtD
Fluvoxamine—Tachycardia—Epirubicin—liver cancer	8.63e-05	0.000632	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Epirubicin—liver cancer	8.55e-05	0.000626	CcSEcCtD
Fluvoxamine—Arthralgia—Doxorubicin—liver cancer	8.54e-05	0.000625	CcSEcCtD
Fluvoxamine—Myalgia—Doxorubicin—liver cancer	8.54e-05	0.000625	CcSEcCtD
Fluvoxamine—Chest pain—Doxorubicin—liver cancer	8.54e-05	0.000625	CcSEcCtD
Fluvoxamine—Anxiety—Doxorubicin—liver cancer	8.51e-05	0.000623	CcSEcCtD
Fluvoxamine—Discomfort—Doxorubicin—liver cancer	8.44e-05	0.000617	CcSEcCtD
Fluvoxamine—Anorexia—Epirubicin—liver cancer	8.43e-05	0.000617	CcSEcCtD
Fluvoxamine—Dry mouth—Doxorubicin—liver cancer	8.35e-05	0.000611	CcSEcCtD
Fluvoxamine—Hypotension—Epirubicin—liver cancer	8.27e-05	0.000605	CcSEcCtD
Fluvoxamine—Confusional state—Doxorubicin—liver cancer	8.25e-05	0.000604	CcSEcCtD
Fluvoxamine—Oedema—Doxorubicin—liver cancer	8.19e-05	0.000599	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Doxorubicin—liver cancer	8.19e-05	0.000599	CcSEcCtD
Fluvoxamine—Infection—Doxorubicin—liver cancer	8.13e-05	0.000595	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Epirubicin—liver cancer	8.06e-05	0.00059	CcSEcCtD
Fluvoxamine—Shock—Doxorubicin—liver cancer	8.05e-05	0.000589	CcSEcCtD
Fluvoxamine—Nervous system disorder—Doxorubicin—liver cancer	8.03e-05	0.000587	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Doxorubicin—liver cancer	8.01e-05	0.000586	CcSEcCtD
Fluvoxamine—Insomnia—Epirubicin—liver cancer	8e-05	0.000585	CcSEcCtD
Fluvoxamine—Tachycardia—Doxorubicin—liver cancer	7.99e-05	0.000585	CcSEcCtD
Fluvoxamine—Paraesthesia—Epirubicin—liver cancer	7.94e-05	0.000581	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Doxorubicin—liver cancer	7.91e-05	0.000579	CcSEcCtD
Fluvoxamine—Dyspnoea—Epirubicin—liver cancer	7.89e-05	0.000577	CcSEcCtD
Fluvoxamine—Somnolence—Epirubicin—liver cancer	7.86e-05	0.000575	CcSEcCtD
Fluvoxamine—Anorexia—Doxorubicin—liver cancer	7.8e-05	0.000571	CcSEcCtD
Fluvoxamine—Dyspepsia—Epirubicin—liver cancer	7.79e-05	0.00057	CcSEcCtD
Fluvoxamine—Decreased appetite—Epirubicin—liver cancer	7.69e-05	0.000563	CcSEcCtD
Fluvoxamine—Hypotension—Doxorubicin—liver cancer	7.65e-05	0.00056	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Epirubicin—liver cancer	7.64e-05	0.000559	CcSEcCtD
Fluvoxamine—Fatigue—Epirubicin—liver cancer	7.63e-05	0.000558	CcSEcCtD
Fluvoxamine—Constipation—Epirubicin—liver cancer	7.57e-05	0.000554	CcSEcCtD
Fluvoxamine—Pain—Epirubicin—liver cancer	7.57e-05	0.000554	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Doxorubicin—liver cancer	7.46e-05	0.000546	CcSEcCtD
Fluvoxamine—Insomnia—Doxorubicin—liver cancer	7.4e-05	0.000542	CcSEcCtD
Fluvoxamine—Paraesthesia—Doxorubicin—liver cancer	7.35e-05	0.000538	CcSEcCtD
Fluvoxamine—Dyspnoea—Doxorubicin—liver cancer	7.3e-05	0.000534	CcSEcCtD
Fluvoxamine—Feeling abnormal—Epirubicin—liver cancer	7.29e-05	0.000533	CcSEcCtD
Fluvoxamine—Somnolence—Doxorubicin—liver cancer	7.28e-05	0.000532	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Epirubicin—liver cancer	7.23e-05	0.000529	CcSEcCtD
Fluvoxamine—Dyspepsia—Doxorubicin—liver cancer	7.21e-05	0.000527	CcSEcCtD
Fluvoxamine—Decreased appetite—Doxorubicin—liver cancer	7.12e-05	0.000521	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Doxorubicin—liver cancer	7.07e-05	0.000517	CcSEcCtD
Fluvoxamine—Fatigue—Doxorubicin—liver cancer	7.06e-05	0.000516	CcSEcCtD
Fluvoxamine—Urticaria—Epirubicin—liver cancer	7.03e-05	0.000514	CcSEcCtD
Fluvoxamine—Constipation—Doxorubicin—liver cancer	7e-05	0.000512	CcSEcCtD
Fluvoxamine—Pain—Doxorubicin—liver cancer	7e-05	0.000512	CcSEcCtD
Fluvoxamine—Abdominal pain—Epirubicin—liver cancer	6.99e-05	0.000512	CcSEcCtD
Fluvoxamine—Body temperature increased—Epirubicin—liver cancer	6.99e-05	0.000512	CcSEcCtD
Fluvoxamine—Feeling abnormal—Doxorubicin—liver cancer	6.75e-05	0.000494	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Doxorubicin—liver cancer	6.69e-05	0.00049	CcSEcCtD
Fluvoxamine—Hypersensitivity—Epirubicin—liver cancer	6.52e-05	0.000477	CcSEcCtD
Fluvoxamine—Urticaria—Doxorubicin—liver cancer	6.5e-05	0.000476	CcSEcCtD
Fluvoxamine—Abdominal pain—Doxorubicin—liver cancer	6.47e-05	0.000473	CcSEcCtD
Fluvoxamine—Body temperature increased—Doxorubicin—liver cancer	6.47e-05	0.000473	CcSEcCtD
Fluvoxamine—Asthenia—Epirubicin—liver cancer	6.35e-05	0.000464	CcSEcCtD
Fluvoxamine—Pruritus—Epirubicin—liver cancer	6.26e-05	0.000458	CcSEcCtD
Fluvoxamine—Diarrhoea—Epirubicin—liver cancer	6.05e-05	0.000443	CcSEcCtD
Fluvoxamine—Hypersensitivity—Doxorubicin—liver cancer	6.03e-05	0.000441	CcSEcCtD
Fluvoxamine—Asthenia—Doxorubicin—liver cancer	5.87e-05	0.00043	CcSEcCtD
Fluvoxamine—Dizziness—Epirubicin—liver cancer	5.85e-05	0.000428	CcSEcCtD
Fluvoxamine—Pruritus—Doxorubicin—liver cancer	5.79e-05	0.000424	CcSEcCtD
Fluvoxamine—Vomiting—Epirubicin—liver cancer	5.62e-05	0.000412	CcSEcCtD
Fluvoxamine—Diarrhoea—Doxorubicin—liver cancer	5.6e-05	0.00041	CcSEcCtD
Fluvoxamine—Rash—Epirubicin—liver cancer	5.58e-05	0.000408	CcSEcCtD
Fluvoxamine—Dermatitis—Epirubicin—liver cancer	5.57e-05	0.000408	CcSEcCtD
Fluvoxamine—Headache—Epirubicin—liver cancer	5.54e-05	0.000406	CcSEcCtD
Fluvoxamine—Dizziness—Doxorubicin—liver cancer	5.41e-05	0.000396	CcSEcCtD
Fluvoxamine—Nausea—Epirubicin—liver cancer	5.25e-05	0.000385	CcSEcCtD
Fluvoxamine—Vomiting—Doxorubicin—liver cancer	5.2e-05	0.000381	CcSEcCtD
Fluvoxamine—Rash—Doxorubicin—liver cancer	5.16e-05	0.000378	CcSEcCtD
Fluvoxamine—Dermatitis—Doxorubicin—liver cancer	5.16e-05	0.000377	CcSEcCtD
Fluvoxamine—Headache—Doxorubicin—liver cancer	5.13e-05	0.000375	CcSEcCtD
Fluvoxamine—Nausea—Doxorubicin—liver cancer	4.86e-05	0.000356	CcSEcCtD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—ALB—liver cancer	9.8e-06	0.000127	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PSMA4—liver cancer	9.77e-06	0.000127	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PSMD10—liver cancer	9.77e-06	0.000127	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	9.76e-06	0.000126	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CYP2E1—liver cancer	9.68e-06	0.000125	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—GOT2—liver cancer	9.51e-06	0.000123	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CYP2E1—liver cancer	9.46e-06	0.000123	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CRABP1—liver cancer	9.44e-06	0.000122	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GSTA4—liver cancer	9.41e-06	0.000122	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—CYP1A1—liver cancer	9.4e-06	0.000122	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CRABP1—liver cancer	9.36e-06	0.000121	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	9.24e-06	0.00012	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	9.19e-06	0.000119	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GSTA2—liver cancer	9.17e-06	0.000119	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CYCS—liver cancer	9.05e-06	0.000117	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—HPGDS—liver cancer	8.97e-06	0.000116	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CYP2E1—liver cancer	8.94e-06	0.000116	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	8.92e-06	0.000116	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—GOT1—liver cancer	8.89e-06	0.000115	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—GGT1—liver cancer	8.89e-06	0.000115	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CYCS—liver cancer	8.87e-06	0.000115	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CYCS—liver cancer	8.85e-06	0.000115	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GSTA1—liver cancer	8.84e-06	0.000115	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—MTHFR—liver cancer	8.76e-06	0.000114	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—HPGDS—liver cancer	8.76e-06	0.000113	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—NAT2—liver cancer	8.74e-06	0.000113	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—GGT1—liver cancer	8.7e-06	0.000113	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—GOT1—liver cancer	8.7e-06	0.000113	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—GOT1—liver cancer	8.68e-06	0.000113	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—GGT1—liver cancer	8.68e-06	0.000113	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	8.65e-06	0.000112	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PPARA—liver cancer	8.6e-06	0.000111	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	8.43e-06	0.000109	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	8.41e-06	0.000109	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ALDOB—liver cancer	8.38e-06	0.000109	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CPT1B—liver cancer	8.37e-06	0.000108	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GLUL—liver cancer	8.37e-06	0.000108	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CYCS—liver cancer	8.36e-06	0.000108	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—HPGDS—liver cancer	8.25e-06	0.000107	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	8.24e-06	0.000107	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—GGT1—liver cancer	8.21e-06	0.000106	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—GOT1—liver cancer	8.21e-06	0.000106	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—HPGDS—liver cancer	8.18e-06	0.000106	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	8.13e-06	0.000105	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	8.12e-06	0.000105	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—NR1H4—liver cancer	8.07e-06	0.000105	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	8.02e-06	0.000104	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CRABP1—liver cancer	8e-06	0.000104	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PSMA4—liver cancer	8e-06	0.000104	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PSMD10—liver cancer	8e-06	0.000104	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—GSTP1—liver cancer	7.98e-06	0.000103	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GSTA3—liver cancer	7.94e-06	0.000103	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—HMOX1—liver cancer	7.87e-06	0.000102	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—GSTP1—liver cancer	7.82e-06	0.000101	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PSMD10—liver cancer	7.8e-06	0.000101	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PSMA4—liver cancer	7.8e-06	0.000101	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—GSTP1—liver cancer	7.8e-06	0.000101	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GOT2—liver cancer	7.78e-06	0.000101	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—HMOX1—liver cancer	7.71e-06	9.99e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—HMOX1—liver cancer	7.69e-06	9.97e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GOT2—liver cancer	7.59e-06	9.84e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	7.44e-06	9.65e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	7.41e-06	9.6e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—GSTP1—liver cancer	7.37e-06	9.55e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PIK3CG—liver cancer	7.36e-06	9.54e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PSMA4—liver cancer	7.35e-06	9.53e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PSMD10—liver cancer	7.35e-06	9.53e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—GSTM1—liver cancer	7.33e-06	9.51e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CYP2E1—liver cancer	7.31e-06	9.48e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	7.31e-06	9.48e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PSMD10—liver cancer	7.29e-06	9.45e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PSMA4—liver cancer	7.29e-06	9.45e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—HMOX1—liver cancer	7.27e-06	9.42e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GSTA4—liver cancer	7.26e-06	9.41e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	7.2e-06	9.33e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—GSTM1—liver cancer	7.18e-06	9.31e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—GSTM1—liver cancer	7.17e-06	9.29e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GOT2—liver cancer	7.15e-06	9.27e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CYP2E1—liver cancer	7.14e-06	9.25e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PPARG—liver cancer	7.11e-06	9.21e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GOT2—liver cancer	7.09e-06	9.19e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	7.08e-06	9.18e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GSTA2—liver cancer	7.07e-06	9.17e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—HPGDS—liver cancer	6.99e-06	9.06e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CYP1A1—liver cancer	6.95e-06	9.01e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	6.95e-06	9.01e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CYCS—liver cancer	6.84e-06	8.87e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GSTA1—liver cancer	6.82e-06	8.84e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CYP1A1—liver cancer	6.81e-06	8.83e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CYP1A1—liver cancer	6.8e-06	8.81e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—GSTM1—liver cancer	6.77e-06	8.78e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—NAT2—liver cancer	6.75e-06	8.75e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	6.73e-06	8.72e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CYP2E1—liver cancer	6.73e-06	8.72e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GGT1—liver cancer	6.71e-06	8.7e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GOT1—liver cancer	6.71e-06	8.7e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CYCS—liver cancer	6.68e-06	8.66e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CYP2E1—liver cancer	6.67e-06	8.64e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GOT1—liver cancer	6.55e-06	8.49e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GGT1—liver cancer	6.55e-06	8.49e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—MTHFR—liver cancer	6.48e-06	8.4e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PIK3CD—liver cancer	6.47e-06	8.39e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ALDOB—liver cancer	6.47e-06	8.38e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	6.46e-06	8.37e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—ALB—liver cancer	6.39e-06	8.28e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PPARA—liver cancer	6.36e-06	8.24e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—MTHFR—liver cancer	6.35e-06	8.23e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—MTHFR—liver cancer	6.34e-06	8.21e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	6.33e-06	8.2e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CYCS—liver cancer	6.29e-06	8.16e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	6.25e-06	8.1e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CYCS—liver cancer	6.24e-06	8.09e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PSMA4—liver cancer	6.23e-06	8.07e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PSMD10—liver cancer	6.23e-06	8.07e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PPARA—liver cancer	6.23e-06	8.07e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PPARA—liver cancer	6.22e-06	8.06e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GGT1—liver cancer	6.18e-06	8e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GOT1—liver cancer	6.18e-06	8e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CRABP1—liver cancer	6.17e-06	8e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GOT1—liver cancer	6.12e-06	7.93e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GGT1—liver cancer	6.12e-06	7.93e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GOT2—liver cancer	6.06e-06	7.85e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GSTP1—liver cancer	6.03e-06	7.82e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—MTHFR—liver cancer	5.99e-06	7.76e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—HMOX1—liver cancer	5.95e-06	7.71e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GSTP1—liver cancer	5.89e-06	7.63e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PPARA—liver cancer	5.87e-06	7.61e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—HMOX1—liver cancer	5.81e-06	7.52e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CYP2E1—liver cancer	5.7e-06	7.38e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PIK3CB—liver cancer	5.64e-06	7.31e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GSTP1—liver cancer	5.55e-06	7.19e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GSTM1—liver cancer	5.54e-06	7.18e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	5.52e-06	7.15e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GSTP1—liver cancer	5.5e-06	7.13e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—HMOX1—liver cancer	5.47e-06	7.09e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PIK3CG—liver cancer	5.45e-06	7.06e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—HMOX1—liver cancer	5.42e-06	7.03e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GSTM1—liver cancer	5.41e-06	7.01e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—HPGDS—liver cancer	5.39e-06	6.99e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PIK3CG—liver cancer	5.33e-06	6.91e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CYCS—liver cancer	5.33e-06	6.91e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PIK3CG—liver cancer	5.32e-06	6.9e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	5.27e-06	6.84e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PPARG—liver cancer	5.26e-06	6.81e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CYP1A1—liver cancer	5.25e-06	6.81e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GGT1—liver cancer	5.23e-06	6.78e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GOT1—liver cancer	5.23e-06	6.78e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PPARG—liver cancer	5.15e-06	6.67e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PPARG—liver cancer	5.14e-06	6.66e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CYP1A1—liver cancer	5.13e-06	6.65e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GSTM1—liver cancer	5.1e-06	6.61e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GSTM1—liver cancer	5.05e-06	6.55e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PIK3CG—liver cancer	5.03e-06	6.52e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—MTHFR—liver cancer	4.9e-06	6.35e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PPARG—liver cancer	4.85e-06	6.29e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CYP1A1—liver cancer	4.83e-06	6.26e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PSMA4—liver cancer	4.81e-06	6.23e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PSMD10—liver cancer	4.81e-06	6.23e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PPARA—liver cancer	4.81e-06	6.23e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CYP1A1—liver cancer	4.79e-06	6.21e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PIK3CD—liver cancer	4.79e-06	6.2e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—MTHFR—liver cancer	4.78e-06	6.2e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—ALB—liver cancer	4.73e-06	6.13e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GSTP1—liver cancer	4.7e-06	6.09e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PPARA—liver cancer	4.69e-06	6.08e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PIK3CD—liver cancer	4.69e-06	6.08e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PIK3CD—liver cancer	4.68e-06	6.06e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GOT2—liver cancer	4.68e-06	6.06e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—HMOX1—liver cancer	4.63e-06	6.01e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—ALB—liver cancer	4.63e-06	6e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—ALB—liver cancer	4.62e-06	5.99e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—MTHFR—liver cancer	4.51e-06	5.84e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—MTHFR—liver cancer	4.47e-06	5.79e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PIK3CD—liver cancer	4.42e-06	5.73e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PPARA—liver cancer	4.42e-06	5.73e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYP2E1—liver cancer	4.4e-06	5.7e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PPARA—liver cancer	4.38e-06	5.68e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—ALB—liver cancer	4.36e-06	5.66e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GSTM1—liver cancer	4.32e-06	5.6e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.32e-06	5.59e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PIK3CB—liver cancer	4.17e-06	5.41e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PIK3CG—liver cancer	4.12e-06	5.33e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYCS—liver cancer	4.11e-06	5.33e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CYP1A1—liver cancer	4.09e-06	5.31e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PIK3CB—liver cancer	4.09e-06	5.3e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PIK3CB—liver cancer	4.08e-06	5.29e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GOT1—liver cancer	4.04e-06	5.23e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GGT1—liver cancer	4.04e-06	5.23e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PIK3CG—liver cancer	4.02e-06	5.21e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PPARG—liver cancer	3.97e-06	5.15e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.94e-06	5.1e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PPARG—liver cancer	3.88e-06	5.02e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PIK3CB—liver cancer	3.85e-06	4.99e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—MTHFR—liver cancer	3.82e-06	4.95e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PIK3CG—liver cancer	3.79e-06	4.91e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PIK3CG—liver cancer	3.75e-06	4.86e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PPARA—liver cancer	3.74e-06	4.85e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PPARG—liver cancer	3.65e-06	4.73e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GSTP1—liver cancer	3.63e-06	4.7e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PPARG—liver cancer	3.62e-06	4.69e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PIK3CD—liver cancer	3.62e-06	4.69e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—HMOX1—liver cancer	3.58e-06	4.64e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ALB—liver cancer	3.57e-06	4.63e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PIK3CD—liver cancer	3.53e-06	4.58e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—ALB—liver cancer	3.49e-06	4.52e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PIK3CA—liver cancer	3.44e-06	4.46e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.36e-06	4.36e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GSTM1—liver cancer	3.33e-06	4.32e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PIK3CD—liver cancer	3.33e-06	4.31e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PIK3CD—liver cancer	3.3e-06	4.28e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ALB—liver cancer	3.28e-06	4.26e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ALB—liver cancer	3.26e-06	4.22e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PIK3CG—liver cancer	3.21e-06	4.16e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYP1A1—liver cancer	3.16e-06	4.09e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PIK3CB—liver cancer	3.15e-06	4.09e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PPARG—liver cancer	3.09e-06	4.01e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PIK3CB—liver cancer	3.08e-06	3.99e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—MTHFR—liver cancer	2.95e-06	3.82e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PIK3CB—liver cancer	2.9e-06	3.76e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PPARA—liver cancer	2.89e-06	3.75e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PIK3CB—liver cancer	2.88e-06	3.73e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PIK3CD—liver cancer	2.82e-06	3.65e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—AKT1—liver cancer	2.81e-06	3.64e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ALB—liver cancer	2.78e-06	3.61e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PIK3CA—liver cancer	2.54e-06	3.3e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PIK3CA—liver cancer	2.49e-06	3.23e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PIK3CA—liver cancer	2.49e-06	3.22e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PIK3CG—liver cancer	2.47e-06	3.21e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PIK3CB—liver cancer	2.46e-06	3.18e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PPARG—liver cancer	2.39e-06	3.1e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PIK3CA—liver cancer	2.35e-06	3.04e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PIK3CD—liver cancer	2.18e-06	2.82e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ALB—liver cancer	2.15e-06	2.78e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—AKT1—liver cancer	2.08e-06	2.69e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—AKT1—liver cancer	2.04e-06	2.64e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—AKT1—liver cancer	2.03e-06	2.63e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PIK3CA—liver cancer	1.92e-06	2.49e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—AKT1—liver cancer	1.92e-06	2.49e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PIK3CB—liver cancer	1.9e-06	2.46e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PIK3CA—liver cancer	1.88e-06	2.43e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PIK3CA—liver cancer	1.77e-06	2.29e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PIK3CA—liver cancer	1.75e-06	2.27e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—AKT1—liver cancer	1.57e-06	2.04e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—AKT1—liver cancer	1.53e-06	1.99e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PIK3CA—liver cancer	1.5e-06	1.94e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—AKT1—liver cancer	1.44e-06	1.87e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—AKT1—liver cancer	1.43e-06	1.86e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—AKT1—liver cancer	1.22e-06	1.59e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PIK3CA—liver cancer	1.16e-06	1.5e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—AKT1—liver cancer	9.44e-07	1.22e-05	CbGpPWpGaD
